Verapamil responsive incessant ventricular tachycardia resulting in severe ventricular dysfunction in a young child: successful management with oral verapamil.
Verapamil responsive incessant ventricular tachycardia resulting in severe ventricular dysfunction in a young child: successful management with oral verapamil.
复制标题
维拉帕米反应性持续性室性心动过速导致幼儿严重心室功能障碍：口服维拉帕米的成功治疗。
作者：
Jae;B. Kim;Jeong
对于持续性室性心动过速和严重心室功能障碍的幼儿，使用常规抗心律失常药物治疗心动过速仍然是一个主要的治疗挑战，因为大多数这些药物可以进一步抑制心肌功能。我们报告一名四岁男孩，他有维拉帕米反应性不间断室性心动过速和严重的心室功能障碍，口服维拉帕米治疗可消除心律失常和扩张性心肌病的症状。口服维拉帕米后，患者无症状，随访10个月无室性心动过速复发。
In young children with incessant ventricular tachycardia and severe ventricular dysfunction, the management of tachycardia with conventional antiarrhythmic drugs remains a major therapeutic challenge because most of these drugs can further depress myocardial function. We report a four year old boy with verapamil responsive incessant ventricular tachycardia and severe ventricular dysfunction in whom oral verapamil treatment eliminated both the arrhythmia and the picture of dilated cardiomyopathy. On oral verapamil, the patient remains asymptomatic without recurrence of the ventricular tachycardia over a follow up period of 10 months.